Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development of anti-cancer therapeutics. It also commercializes a technology platform that is intended for the chemical modification of protein therapeutics. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Boston, MA.
Company profile
Ticker
APTCF
Exchange
Website
CEO
Paul Woodward / William H. Dickie
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Thrilltime Entertainment International Inc
SEC CIK
APTCF stock data
Latest filings (excl ownership)
D
$342.29K in equity / options / securities to be acquired, sold $127.15K, 3 investors
26 May 20
D
$38.41K in equity / options / securities to be acquired, sold $15.37K, 1 investor
4 Sep 18
D
$450K in equity / options / securities to be acquired, sold $97.5K, 2 investors
3 Nov 16
D
$217.41K in equity / options / securities to be acquired, sold $217.41K, 23 investors
25 May 16
D
$160.05K in equity / options / securities to be acquired, sold $160.05K, 5 investors
28 Feb 13
D
$690K in equity / options / securities to be acquired, sold $690K, 39 investors
14 Feb 13
D
$292.9K in equity / options / securities to be acquired, sold $292.9K, 8 investors
11 Sep 12
D
$35K in debt, sold $35K, 6 investors
2 Mar 12
D
$900K in equity / options / securities to be acquired, sold $900K, 24 investors
8 Nov 10
15F-12G
Securities registration termination (foreign)
22 Oct 08
Latest ownership filings
No filings